WO2004032963A3 - Photokinetic delivery of biologically active substances using pulsed incoherent light - Google Patents

Photokinetic delivery of biologically active substances using pulsed incoherent light Download PDF

Info

Publication number
WO2004032963A3
WO2004032963A3 PCT/US2003/031532 US0331532W WO2004032963A3 WO 2004032963 A3 WO2004032963 A3 WO 2004032963A3 US 0331532 W US0331532 W US 0331532W WO 2004032963 A3 WO2004032963 A3 WO 2004032963A3
Authority
WO
WIPO (PCT)
Prior art keywords
biologically active
active substances
incoherent light
pulsed incoherent
cellular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2003/031532
Other languages
French (fr)
Other versions
WO2004032963A2 (en
WO2004032963A9 (en
Inventor
Edward R Kraft
Gabriela Kulp
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Photokinetix Inc
Original Assignee
Photokinetix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Photokinetix Inc filed Critical Photokinetix Inc
Priority to DE60313353T priority Critical patent/DE60313353T2/en
Priority to EP03774568A priority patent/EP1556061B1/en
Priority to CA2500713A priority patent/CA2500713C/en
Priority to AU2003282683A priority patent/AU2003282683A1/en
Publication of WO2004032963A2 publication Critical patent/WO2004032963A2/en
Publication of WO2004032963A3 publication Critical patent/WO2004032963A3/en
Anticipated expiration legal-status Critical
Publication of WO2004032963A9 publication Critical patent/WO2004032963A9/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0042—Photocleavage of drugs in vivo, e.g. cleavage of photolabile linkers in vivo by UV radiation for releasing the pharmacologically-active agent from the administered agent; photothrombosis or photoocclusion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)

Abstract

The invention relates generally to transdermal and transmembrane delivery of biologically active substances through the skin, sub-dermal tissues, blood vessels and cellular membranes without causing damage to the cellular membrane surface, tissue or membrane. The invention provides compositions and methods for enhanced transdermal and transmembrane delivery of biologically active substances using pulsed incoherent light. The invention further provides a device for the application of the pulsed incoherent light to cellular surfaces and membranes using those compositions and methods.
PCT/US2003/031532 2002-10-04 2003-10-03 Photokinetic delivery of biologically active substances using pulsed incoherent light Ceased WO2004032963A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
DE60313353T DE60313353T2 (en) 2002-10-04 2003-10-03 PHOTOKINETIC DELIVERY OF BIOLOGICALLY ACTIVE SUBSTANCES USING PULSATIVE INKOHAERENTEM LIGHT.
EP03774568A EP1556061B1 (en) 2002-10-04 2003-10-03 Photokinetic delivery of biologically active substances using pulsed incoherent light
CA2500713A CA2500713C (en) 2002-10-04 2003-10-03 Photokinetic delivery of biologically active substances using pulsed incoherent light
AU2003282683A AU2003282683A1 (en) 2002-10-04 2003-10-03 Photokinetic delivery of biologically active substances using pulsed incoherent light

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US41636102P 2002-10-04 2002-10-04
US60/416,361 2002-10-04
US47950103P 2003-06-17 2003-06-17
US60/479,501 2003-06-17

Publications (3)

Publication Number Publication Date
WO2004032963A2 WO2004032963A2 (en) 2004-04-22
WO2004032963A3 true WO2004032963A3 (en) 2004-12-16
WO2004032963A9 WO2004032963A9 (en) 2005-04-28

Family

ID=32096146

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/031532 Ceased WO2004032963A2 (en) 2002-10-04 2003-10-03 Photokinetic delivery of biologically active substances using pulsed incoherent light

Country Status (7)

Country Link
US (2) US7458982B2 (en)
EP (1) EP1556061B1 (en)
AT (1) ATE359802T1 (en)
AU (1) AU2003282683A1 (en)
CA (1) CA2500713C (en)
DE (1) DE60313353T2 (en)
WO (1) WO2004032963A2 (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130274837A1 (en) * 1998-10-23 2013-10-17 Babak Nemati Systems and Methods to Enhance Optical Transparency of Biological Tissues for Photobiomodulation
US6219575B1 (en) * 1998-10-23 2001-04-17 Babak Nemati Method and apparatus to enhance optical transparency of biological tissues
DE602004019514D1 (en) * 2003-05-09 2009-04-02 Philips Intellectual Property TREATMENT DEVICE USING SEMICONDUCTOR LIGHT DIODES
GB0525072D0 (en) * 2005-12-09 2006-01-18 Enigma Diagnostics Ltd Fluorescence-based detection methods and apparatus
US20080031833A1 (en) * 2006-03-13 2008-02-07 Oblong John E Combined energy and topical composition application for regulating the condition of mammalian skin
RU2497679C2 (en) 2008-10-02 2013-11-10 Милан Инк. Method of making multilayer adhesive laminated material
HUP0900073A2 (en) * 2009-02-06 2010-11-29 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Process and equipment for inquiry medical product on dermal surface
US8523791B2 (en) * 2009-08-11 2013-09-03 Laboratoire Naturel Paris, Llc Multi-modal drug delivery system
US8948863B2 (en) * 2009-10-09 2015-02-03 Board Of Regents, The University Of Texas System Photokinetic ocular drug delivery methods and apparatus
US9474911B2 (en) 2011-03-29 2016-10-25 Photokinetix Holdings Inc. Delivery of large molecular weight biologically active substances
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
RS62297B1 (en) 2011-11-23 2021-09-30 Therapeuticsmd Inc Natural combination hormone replacement formulations and therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
RU2016143081A (en) 2014-05-22 2018-06-26 Терапьютиксмд, Инк. NATURAL COMBINED HORMONE SUBSTITUTION COMPOSITIONS AND THERAPIES
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
US9931349B2 (en) 2016-04-01 2018-04-03 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations
US11701527B2 (en) 2020-08-31 2023-07-18 B/E Aerospace, Inc. Enclosed system environment pressure regulator
US20240082598A1 (en) * 2021-09-01 2024-03-14 Lumeda Inc. Optical surface applicator with forward and backward projection

Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992010995A1 (en) * 1990-12-19 1992-07-09 Beecham Group Plc Novel compositions
US5306485A (en) * 1991-05-07 1994-04-26 Richardson-Vicks Inc. Suncare compositions
WO1994015666A1 (en) * 1993-01-13 1994-07-21 Pdt Systems, Inc. Light emitting diode source for photodynamic therapy
US5698207A (en) * 1995-07-26 1997-12-16 International Laboratory Technology Corp. Burn treatment composition
WO1998002138A1 (en) * 1996-07-12 1998-01-22 Indústria e Comércio de Cosméticos Natura Ltda. Desiccant composition, in emulsion form, for the skin
US6024968A (en) * 1991-08-16 2000-02-15 Lincoln Technologies Inc. Intersorption composition and method
JP2000237230A (en) * 1999-02-17 2000-09-05 Kyoshin Shoji Co Ltd Photocatalyst fixing adhesive tape
US6387089B1 (en) * 1995-09-15 2002-05-14 Lumenis Ltd. Method and apparatus for skin rejuvination and wrinkle smoothing
EP1238651A1 (en) * 2001-02-27 2002-09-11 Johnson & Johnson Consumer France SAS Agents for potentiating preservatives in sunscreen formulations
DE10208678A1 (en) * 2001-03-09 2002-09-12 Henkel Kgaa Polyurethane foam product for cosmetic or dermatological use comprises the in situ reaction product of a urethane prepolymer with an aqueous dispersion containing selected active ingredients
WO2002100326A2 (en) * 2001-05-01 2002-12-19 The General Hospital Corporation Photoimmunotherapies for cancer using photosensitizer immunoconjugates and combination therapies
EP1340520A1 (en) * 1992-10-23 2003-09-03 Photo Therapeutics Limited Cosmetic treatment of dermatological conditions

Family Cites Families (129)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5135477A (en) 1984-10-29 1992-08-04 Medtronic, Inc. Iontophoretic drug delivery
US4702732A (en) 1984-12-24 1987-10-27 Trustees Of Boston University Electrodes, electrode assemblies, methods, and systems for tissue stimulation and transdermal delivery of pharmacologically active ligands
US4886489A (en) 1986-03-19 1989-12-12 Jacobsen Stephen C Flow-through methods and apparatus for iontophoresis application of medicaments at a controlled pH
IE60941B1 (en) 1986-07-10 1994-09-07 Elan Transdermal Ltd Transdermal drug delivery device
US5961482A (en) 1986-07-25 1999-10-05 Rutgers, The State University Of New Jersey Iontotherapeutic device and process and iontotherapeutic unit dose
US4786277A (en) 1986-11-21 1988-11-22 Trustees Of Boston University Electrodes, electrode assemblies, methods, and systems for tissue stimulation
US4940456A (en) 1987-02-10 1990-07-10 Dan Sibalis Electrolytic transdermal delivery of proteins
US5080646A (en) 1988-10-03 1992-01-14 Alza Corporation Membrane for electrotransport transdermal drug delivery
US4931046A (en) 1987-05-15 1990-06-05 Newman Martin H Iontophoresis drug delivery system
US5749847A (en) 1988-01-21 1998-05-12 Massachusetts Institute Of Technology Delivery of nucleotides into organisms by electroporation
US5156846A (en) 1989-02-23 1992-10-20 University Of Utah Percutaneous drug delivery system
US5167616A (en) 1989-12-14 1992-12-01 Alza Corporation Iontophoretic delivery method
US5084008A (en) 1989-12-22 1992-01-28 Medtronic, Inc. Iontophoresis electrode
US5047007A (en) 1989-12-22 1991-09-10 Medtronic, Inc. Method and apparatus for pulsed iontophoretic drug delivery
US5016615A (en) 1990-02-20 1991-05-21 Riverside Research Institute Local application of medication with ultrasound
US5231975A (en) 1990-02-23 1993-08-03 Cygnus Therapeutic Systems Ultrasound-enhanced delivery of materials into and through the skin
US5115805A (en) 1990-02-23 1992-05-26 Cygnus Therapeutic Systems Ultrasound-enhanced delivery of materials into and through the skin
DE69115471T2 (en) 1990-03-30 1996-05-02 Alza Corp., Palo Alto, Calif. DEVICE FOR IONTOPHORETIC ADMINISTRATION OF MEDICINES
US5125894A (en) 1990-03-30 1992-06-30 Alza Corporation Method and apparatus for controlled environment electrotransport
US6004309A (en) 1990-03-30 1999-12-21 Alza Corporation Method and apparatus for controlled environment electrotransport
US5362308A (en) 1990-09-25 1994-11-08 Rutgers, The State University Of New Jersey Disposable dosage unit for iontophoresis-facilitated transdermal delivery, related devices and processes
US6139537A (en) 1990-11-01 2000-10-31 Tapper; Robert Iontophoretic treatment system
US6235013B1 (en) 1990-11-01 2001-05-22 Robert Tapper Iontophoretic treatment system
US5224927A (en) 1990-11-01 1993-07-06 Robert Tapper Iontophoretic treatment system
US6238381B1 (en) 1990-11-01 2001-05-29 Robert Tapper Iontophoretic treatment system
US5221254A (en) 1991-04-02 1993-06-22 Alza Corporation Method for reducing sensation in iontophoretic drug delivery
US5464387A (en) 1991-07-24 1995-11-07 Alza Corporation Transdermal delivery device
US5203768A (en) 1991-07-24 1993-04-20 Alza Corporation Transdermal delivery device
US5258453A (en) 1992-01-21 1993-11-02 University Of Utah Drug delivery system for the simultaneous delivery of drugs activatable by enzymes and light
ES2120477T3 (en) 1992-01-21 1998-11-01 Macrochem Corp PERFECTED Iontophoretic Administration of Medicines.
FR2688106B1 (en) 1992-02-27 1994-09-09 Lhd Lab Hygiene Dietetique DEVICE FOR GENERATING AN PREDETERMINED WAVEFORM ELECTRIC VOLTAGE, IONOPHORETIC APPARATUS FOR TRANSDERMAL DELIVERY OF MEDICAMENTS.
GB2265088B (en) 1992-03-10 1996-02-07 Kyosti Eero Antero Kontturi Electrochemical device for drug delivery
US6009345A (en) 1992-08-17 1999-12-28 Genetronics, Inc. Method and apparatus for a combination of electroporation and iontophoresis for the delivery of drugs and genes
US5306235A (en) 1992-09-30 1994-04-26 Becton Dickinson And Company Failsafe iontophoresis drug delivery system
US5421816A (en) 1992-10-14 1995-06-06 Endodermic Medical Technologies Company Ultrasonic transdermal drug delivery system
US6315772B1 (en) * 1993-09-24 2001-11-13 Transmedica International, Inc. Laser assisted pharmaceutical delivery and fluid removal
US5527350A (en) * 1993-02-24 1996-06-18 Star Medical Technologies, Inc. Pulsed infrared laser treatment of psoriasis
US5667487A (en) 1993-04-07 1997-09-16 Henley; Julian L. Ionosonic drug delivery apparatus
TW360548B (en) 1993-04-08 1999-06-11 Powderject Res Ltd Products for therapeutic use
US5533971A (en) 1993-09-03 1996-07-09 Alza Corporation Reduction of skin irritation during electrotransport
US5814599A (en) 1995-08-04 1998-09-29 Massachusetts Insitiute Of Technology Transdermal delivery of encapsulated drugs
US5885211A (en) 1993-11-15 1999-03-23 Spectrix, Inc. Microporation of human skin for monitoring the concentration of an analyte
DK0752898T3 (en) 1994-03-30 1999-02-15 Alza Corp Reduction of skin irritation by electrotransport application
JPH09511927A (en) 1994-04-18 1997-12-02 ザ、プロクター、エンド、ギャンブル、カンパニー Iontophoretic delivery of bisphosphonates to alveolar bone
GB2289236B (en) * 1994-05-09 1997-08-06 Boucherie Nv G B A brush making machine
US6048545A (en) 1994-06-24 2000-04-11 Biozone Laboratories, Inc. Liposomal delivery by iontophoresis
US5771890A (en) 1994-06-24 1998-06-30 Cygnus, Inc. Device and method for sampling of substances using alternating polarity
JP4090072B2 (en) 1994-07-13 2008-05-28 アルザ・コーポレーション Compositions and methods for facilitating transdermal electrotransport agent administration
US5540654A (en) 1994-09-02 1996-07-30 North Carolina State University Iontophoretic electrode
US5817144A (en) 1994-10-25 1998-10-06 Latis, Inc. Method for contemporaneous application OF laser energy and localized pharmacologic therapy
US5736580A (en) 1994-11-14 1998-04-07 Alza Croporation Composition, device, and method for electrotransport agent delivery
US5861439A (en) 1994-11-14 1999-01-19 Alza Corporation Method for enhanced electrotransport agent delivery
US5700481A (en) 1995-03-17 1997-12-23 Takeda Chemical Industries, Ltd. Transdermal drug delivery process
US5843014A (en) 1995-03-24 1998-12-01 Alza Corporation Display for an electrotransport delivery device
US6425892B2 (en) 1995-06-05 2002-07-30 Alza Corporation Device for transdermal electrotransport delivery of fentanyl and sufentanil
US6216033B1 (en) 1996-05-22 2001-04-10 Alza Corporation Device for transdermal electrotransport delivery of fentanyl and sufentanil
US5947921A (en) 1995-12-18 1999-09-07 Massachusetts Institute Of Technology Chemical and physical enhancers and ultrasound for transdermal drug delivery
US6002961A (en) 1995-07-25 1999-12-14 Massachusetts Institute Of Technology Transdermal protein delivery using low-frequency sonophoresis
US6041253A (en) 1995-12-18 2000-03-21 Massachusetts Institute Of Technology Effect of electric field and ultrasound for transdermal drug delivery
US6167301A (en) 1995-08-29 2000-12-26 Flower; Ronald J. Iontophoretic drug delivery device having high-efficiency DC-to-DC energy conversion circuit
US20070185552A1 (en) * 1996-02-13 2007-08-09 Leonardo Masotti Device and method for biological tissue stimulation by high intensity laser therapy
FR2747313B1 (en) 1996-04-16 1998-06-05 Lhd Lab Hygiene Dietetique TRANSDERMAL MEDICINE DELIVERY DEVICE BY IONOPHORESIS
US6385487B1 (en) 1996-05-08 2002-05-07 Biophoretic Therapeutic Systems, Llc Methods for electrokinetic delivery of medicaments
WO1997048443A1 (en) * 1996-06-19 1997-12-24 Becton Dickinson And Company Iontophoretic delivery of cell adhesion inhibitors
EP0813887A3 (en) 1996-06-20 1999-11-03 Hisamitsu Pharmaceutical Co. Inc. A device structure for iontophoresis
JP2002515786A (en) 1996-06-28 2002-05-28 ソントラ メディカル，エル．ピー． Ultrasound enhancement of transdermal delivery
US6106514A (en) * 1996-08-12 2000-08-22 O'donnell, Jr.; Francis E. Laser method for subsurface cutaneous treatment
US5947821A (en) * 1996-10-01 1999-09-07 Casino Data Systems Card game
US6024717A (en) 1996-10-24 2000-02-15 Vibrx, Inc. Apparatus and method for sonically enhanced drug delivery
GB9623026D0 (en) 1996-11-06 1997-01-08 Boots Co Ltd Anhydrous compositions
EP0957980A4 (en) 1996-11-27 2000-03-29 Gen Hospital Corp DELIVERY OF COMPOUNDS BY MEANS OF IMPULSE TRANSIENT PHENOMENES
US6162211A (en) 1996-12-05 2000-12-19 Thermolase Corporation Skin enhancement using laser light
US5999678A (en) 1996-12-27 1999-12-07 Eclipse Surgical Technologies, Inc. Laser delivery means adapted for drug delivery
US6085115A (en) 1997-05-22 2000-07-04 Massachusetts Institite Of Technology Biopotential measurement including electroporation of tissue surface
US5954675A (en) 1997-07-07 1999-09-21 Dellagatta; Enrico Michael Method of ultrasonic therapy
CA2305721C (en) * 1997-10-08 2009-02-24 The General Hospital Corporation Phototherapy methods and systems
GB9721506D0 (en) * 1997-10-10 1997-12-10 Virulite Limited Treatment of diseases
TW368420B (en) 1997-11-04 1999-09-01 Genetronics Inc Apparatus and method for transdermal molecular delivery by applying sufficient amplitude of electric field to induce migration of molecules through pores in the stratum corneum
US6071944A (en) * 1997-11-12 2000-06-06 Bowling Green State University Method of treatment of pigmented cancer cells utilizing photodynamic therapy
US6295469B1 (en) 1997-11-14 2001-09-25 Alza Corporation Formulation for electrically assisted delivery of lidocaine and epinephrine
US5941821A (en) * 1997-11-25 1999-08-24 Trw Inc. Method and apparatus for noninvasive measurement of blood glucose by photoacoustics
AU2090099A (en) 1997-12-16 1999-07-05 William Darwin Garner Reduction of uv induced skin cancer by topical amines
USRE37796E1 (en) 1997-12-16 2002-07-23 Biophoretic Therapeutic Systems, Llc Methods for iontophoretic delivery of antiviral agents
US6235381B1 (en) * 1997-12-30 2001-05-22 The Boeing Company Reinforced ceramic structures
WO1999034868A1 (en) * 1998-01-07 1999-07-15 Kim Robin Segal Diode laser irradiation and electrotherapy system for biological tissue stimulation
EP1045714A1 (en) 1998-01-08 2000-10-25 Sontra Medical, L.P. Sonophoretic enhanced transdermal transport
US6221068B1 (en) * 1998-01-15 2001-04-24 Northwestern University Method for welding tissue
US6165170A (en) * 1998-01-29 2000-12-26 International Business Machines Corporation Laser dermablator and dermablation
US6059736A (en) 1998-02-24 2000-05-09 Tapper; Robert Sensor controlled analysis and therapeutic delivery system
US6030374A (en) 1998-05-29 2000-02-29 Mcdaniel; David H. Ultrasound enhancement of percutaneous drug absorption
US6398753B2 (en) 1998-04-03 2002-06-04 Mcdaniel David H. Ultrasound enhancement of percutaneous drug absorption
US6322532B1 (en) 1998-06-24 2001-11-27 3M Innovative Properties Company Sonophoresis method and apparatus
US6148231A (en) 1998-09-15 2000-11-14 Biophoretic Therapeutic Systems, Llc Iontophoretic drug delivery electrodes and method
DE69904956T2 (en) 1998-10-28 2003-11-13 Cygnus, Inc. TEST SET AND METHOD FOR QUALITY TESTING OF AN IONTOPHORETIC SAMPLING SYSTEM
US6283956B1 (en) 1998-11-30 2001-09-04 David H. McDaniels Reduction, elimination, or stimulation of hair growth
US6389313B1 (en) * 1999-03-26 2002-05-14 Kevin S. Marchitto Laser probes for drug permeation
US6379324B1 (en) 1999-06-09 2002-04-30 The Procter & Gamble Company Intracutaneous microneedle array apparatus
US20040122492A1 (en) * 1999-07-07 2004-06-24 Yoram Harth Phototherapeutic treatment of skin conditions
US6669951B2 (en) * 1999-08-24 2003-12-30 Cellgate, Inc. Compositions and methods for enhancing drug delivery across and into epithelial tissues
US6421561B1 (en) 1999-12-30 2002-07-16 Birch Point Medical, Inc. Rate adjustable drug delivery system
EP1268474A2 (en) 2000-03-30 2003-01-02 Takeda Chemical Industries, Ltd. Substituted 1,3-thiazole compounds, their production and use
US6904073B2 (en) 2001-01-29 2005-06-07 Cymer, Inc. High power deep ultraviolet laser with long life optics
AU2001290552A1 (en) 2000-09-15 2002-03-26 Medical Merchandising, Inc. Pain reliever and method of use
US7450618B2 (en) * 2001-01-30 2008-11-11 Board Of Trustees Operating Michigan State University Laser system using ultrashort laser pulses
TWI233361B (en) 2001-04-13 2005-06-01 Gen Hospital Corp Methods of preventing UVB-induced skin damage
US7150710B2 (en) * 2001-06-26 2006-12-19 Photomed Technologies, Inc. Therapeutic methods using electromagnetic radiation
GB0127581D0 (en) * 2001-11-17 2002-01-09 Univ St Andrews Therapeutic Light-emitting device
AUPS051002A0 (en) * 2002-02-14 2002-03-07 Riancorp Pty Ltd Low level laser therapy method and means
US20030191458A1 (en) 2002-04-03 2003-10-09 Cornelius Diamond Light-activated drug delivery method and device
AU2003230808A1 (en) * 2002-04-05 2003-10-27 Candela Corporation High fluence rate activation of photosensitizers for dermatological applications
IL150914A (en) * 2002-07-25 2014-04-30 Zamir Tribelsky A method for hydro-optronio photochemical treatment of liquids
US20040048842A1 (en) * 2002-09-10 2004-03-11 Mcmillan Kathleen Method of treating skin disorders
US7931028B2 (en) * 2003-08-26 2011-04-26 Jay Harvey H Skin injury or damage prevention method using optical radiation
JP2006511275A (en) 2002-12-20 2006-04-06 パロマー・メディカル・テクノロジーズ・インコーポレイテッド Phototherapy device for acne and other hair follicle disorders
ES2570985T3 (en) * 2003-02-25 2016-05-23 Tria Beauty Inc Apparatus and procedure for inhibiting new hair growth, safe for the eye and autonomous
AU2003221663A1 (en) 2003-04-23 2004-11-19 Qlt Inc. Hair growth
US20050010271A1 (en) * 2003-07-07 2005-01-13 Merchant Robert F. Method of using radiation to treat cutaneous and sub-cutaneous conditions
CA2437638A1 (en) * 2003-08-20 2005-02-20 John Robert North Photodynamic therapy
US20050203593A1 (en) * 2003-10-24 2005-09-15 Shanks Steven C. Method for dermatology therapies in combination with low level laser treatments
DE602004032400D1 (en) * 2003-11-05 2011-06-01 Photobiomed Corp Connecting tissues and crosslinking proteins with naphthalimide compounds
JP4971133B2 (en) 2004-04-01 2012-07-11 ザ ジェネラル ホスピタル コーポレイション Equipment for dermatological treatment
US20050245998A1 (en) 2004-04-30 2005-11-03 Led Healing Light, Llc Hand held pulse laser for therapeutic use
US8109981B2 (en) 2005-01-25 2012-02-07 Valam Corporation Optical therapies and devices
US20060173514A1 (en) * 2005-02-02 2006-08-03 Advanced Photodynamic Technologies, Inc. Wound treatment device for photodynamic therapy and method of using same
WO2007025244A2 (en) 2005-08-25 2007-03-01 Houle Philip R Treatment systems for delivery of sensitizer solutions
US20070219600A1 (en) * 2006-03-17 2007-09-20 Michael Gertner Devices and methods for targeted nasal phototherapy
WO2007122611A2 (en) * 2006-04-20 2007-11-01 Nano Pass Technologies Ltd. Device and methods combining vibrating micro-protrusions with phototherapy
US20080234669A1 (en) * 2007-03-19 2008-09-25 Kauvar Arielle N B Method and device for treating skin by superficial coagulation
US20090012515A1 (en) * 2007-07-06 2009-01-08 Hoenig Peter A Devices, systems and methods for treating tissues

Patent Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992010995A1 (en) * 1990-12-19 1992-07-09 Beecham Group Plc Novel compositions
US5306485A (en) * 1991-05-07 1994-04-26 Richardson-Vicks Inc. Suncare compositions
US6024968A (en) * 1991-08-16 2000-02-15 Lincoln Technologies Inc. Intersorption composition and method
EP1340520A1 (en) * 1992-10-23 2003-09-03 Photo Therapeutics Limited Cosmetic treatment of dermatological conditions
WO1994015666A1 (en) * 1993-01-13 1994-07-21 Pdt Systems, Inc. Light emitting diode source for photodynamic therapy
US5698207A (en) * 1995-07-26 1997-12-16 International Laboratory Technology Corp. Burn treatment composition
US6387089B1 (en) * 1995-09-15 2002-05-14 Lumenis Ltd. Method and apparatus for skin rejuvination and wrinkle smoothing
WO1998002138A1 (en) * 1996-07-12 1998-01-22 Indústria e Comércio de Cosméticos Natura Ltda. Desiccant composition, in emulsion form, for the skin
JP2000237230A (en) * 1999-02-17 2000-09-05 Kyoshin Shoji Co Ltd Photocatalyst fixing adhesive tape
EP1238651A1 (en) * 2001-02-27 2002-09-11 Johnson & Johnson Consumer France SAS Agents for potentiating preservatives in sunscreen formulations
DE10208678A1 (en) * 2001-03-09 2002-09-12 Henkel Kgaa Polyurethane foam product for cosmetic or dermatological use comprises the in situ reaction product of a urethane prepolymer with an aqueous dispersion containing selected active ingredients
WO2002100326A2 (en) * 2001-05-01 2002-12-19 The General Hospital Corporation Photoimmunotherapies for cancer using photosensitizer immunoconjugates and combination therapies
US20020197262A1 (en) * 2001-05-01 2002-12-26 Tayyaba Hasan Photoimmunotherapies for cancer using photosensitizer immunoconjugates and combination therapies

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Week 200056, Derwent World Patents Index; AN 2000-591306 *
HUANG ET AL: "The study of the Photokinetic effect and mechanism of ultrafine TiO2 particles on U937 cells", J.OF PHOTOCHEMISTRY AND PHOTOBIOLOGY-A CHEMISTRY, vol. 108, 1997, pages 229 - 233, XP002280156 *
JIANG F N ET AL: "ENHANCED PHOTODYNAMIC KILLING OF TARGET CELLS BY EITHER MONOCLONAL ANTIBODY OR LOW DENSITY LIPOPROTEIN MEDIATED DELIVERY SYSTEMS", JOURNAL OF CONTROLLED RELEASE, ELSEVIER SCIENCE PUBLISHERS B.V. AMSTERDAM, NL, vol. 19, no. 1 / 3, 1 March 1992 (1992-03-01), pages 41 - 58, XP000261528, ISSN: 0168-3659 *

Also Published As

Publication number Publication date
US20090156463A1 (en) 2009-06-18
CA2500713A1 (en) 2004-04-22
CA2500713C (en) 2012-07-03
AU2003282683A1 (en) 2004-05-04
EP1556061B1 (en) 2007-04-18
WO2004032963A2 (en) 2004-04-22
ATE359802T1 (en) 2007-05-15
DE60313353T2 (en) 2007-08-16
US7854753B2 (en) 2010-12-21
DE60313353D1 (en) 2007-05-31
AU2003282683A8 (en) 2004-05-04
WO2004032963A9 (en) 2005-04-28
EP1556061A2 (en) 2005-07-27
US20040131687A1 (en) 2004-07-08
US7458982B2 (en) 2008-12-02

Similar Documents

Publication Publication Date Title
AU2003282683A1 (en) Photokinetic delivery of biologically active substances using pulsed incoherent light
WO2006009786A3 (en) Intravascular imaging device and uses thereof
EP2422768A3 (en) Penetrating pharmaceutical foam
WO2005034763A8 (en) Devices, systems, and methods for suturing tissue
WO2008045228A3 (en) Medical devices having porous regions for controlled therapeutic agent exposure or delivery
WO2004021968A3 (en) Solution for ungual application
AU2003250060A1 (en) Cotton swab used for cosmetic or medical purposes or for body care
WO2007137211A3 (en) Tissue synthetic-biomaterial hybrid medical devices
EA200901112A1 (en) LIQUID COMPOSITIONS FORMING DERMAL FILMS FOR INTRODUCTION OF MEDICINAL PREPARATIONS IN THE SKIN
EP2283851A3 (en) Compositions and methods for promoting hemostasis and other physiological activities
EP2289569A3 (en) Collagen device and method of preparing the same
BRPI0517501A (en) medical device suitable for use in the administration of an active ingredient to or through the skin
AU2002359490A1 (en) Microneedle devices and methods of manufacture
WO2008127373A3 (en) Methods and devices for treating tissue
DK0974350T3 (en) Tranilast-containing composition for external application and method for preparing it
WO2000056354A3 (en) Methods of using agents that act on the epithelial sheet of a human eye
EA200601129A1 (en) METHOD OF TREATMENT OF UNDESIRABLE EFFECT IN TRANSACTION DELIVERY OF THE MEDICINE (OPTIONS)
EP2289574A3 (en) Medical devices and methods of making medical devices
AU2002234021A1 (en) Method and device for the treatment of vulnerable tissue site
WO2008092011A3 (en) Biofilm-inhibiting medical products
WO2006077427A3 (en) Antiviral drug combinations
WO2005000985A3 (en) Antimicrobial phenol containing cyanoacrylate adhesive compositions
WO2006062679A3 (en) Bandage and method for vital bleaching of skin
IT1304503B1 (en) USE OF A SELECTIVE MEMBRANE IN A BIOMEDICAL DEVICE FOR THE EXTRA-BODY TREATMENT OF BLOOD AND OTHER ORGANIC LIQUIDS.
WO2007062386A3 (en) Hair follicle graft from tissue engineered skin

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2500713

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2003774568

Country of ref document: EP

COP Corrected version of pamphlet

Free format text: PAGES 12, 21, 34, 61 AND 64, DESCRIPTION, REPLACED BY NEW PAGES 12, 21, 34, 61 AND 64; AFTER RECTIFICATION OF OBVIOUS ERRORS AUTHORIZED BY THE INTERNATIONAL SEARCH AUTHORITY

WWP Wipo information: published in national office

Ref document number: 2003774568

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP

WWG Wipo information: grant in national office

Ref document number: 2003774568

Country of ref document: EP